Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01598272 · ClinicalTrials.gov registry record · Phase 4
Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women
A Phase 4 study, sponsored by Pharmanex.
- Completed
- Registry status
- Phase 4
- Development phase
- 95
- Enrollment target
NCT01598272: Completed Phase 4 study, sponsored by Pharmanex.
NCT01598272 is a Phase 4 study that has completed, run by Pharmanex. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01598272, a Phase 4 study, has completed, sponsored by Pharmanex.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 95 participants
- Enrollment target
Study Summary
Determine the effects of 8 week Investigational Supplement on cellular detoxification and gene expression profiles
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitality product AM + Vitality product PM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01598272
The ClinicalTrials.gov registry entry for NCT01598272 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pharmanex, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01598272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01598272 about?
NCT01598272 is a clinical study titled "Effects of a Proprietary Blend of Herbal Extract Supplement on Cellular Detoxification, Inflammation, and Cumulative Cognitive Index as Well as Gene Expression in Middle-Aged Adult Women". Determine the effects of 8 week Investigational Supplement on cellular detoxification and gene expression profiles
What is the current status of trial NCT01598272?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 95 participants. The study started on 2011-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01598272?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitality product AM + Vitality product PM (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01598272?
This trial is sponsored by Pharmanex, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.